Copyright Reports & Markets. All rights reserved.

Global Platinum-based Anticancer Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Platinum-based Anticancer Drugs Market Overview

  • 1.1 Product Overview and Scope of Platinum-based Anticancer Drugs
  • 1.2 Platinum-based Anticancer Drugs Segment by Type
    • 1.2.1 Global Platinum-based Anticancer Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Cisplatin
    • 1.2.3 Carboplatin
    • 1.2.4 Oxaliplatin
    • 1.2.5 Nedaplatin
    • 1.2.6 Others
  • 1.3 Platinum-based Anticancer Drugs Segment by Application
    • 1.3.1 Platinum-based Anticancer Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Testicular Cancer
    • 1.3.3 Osteosarcoma
    • 1.3.4 Breast Cancer
    • 1.3.5 Esophageal Cancer
    • 1.3.6 NSCLC
    • 1.3.7 Other
  • 1.4 Global Platinum-based Anticancer Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Platinum-based Anticancer Drugs Revenue 2016-2027
    • 1.4.2 Global Platinum-based Anticancer Drugs Sales 2016-2027
    • 1.4.3 Platinum-based Anticancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Platinum-based Anticancer Drugs Market Competition by Manufacturers

  • 2.1 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Platinum-based Anticancer Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Platinum-based Anticancer Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Platinum-based Anticancer Drugs Market Competitive Situation and Trends
    • 2.5.1 Platinum-based Anticancer Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Platinum-based Anticancer Drugs Players Market Share by Revenue
    • 2.5.3 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Platinum-based Anticancer Drugs Retrospective Market Scenario by Region

  • 3.1 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Platinum-based Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.3.1 North America Platinum-based Anticancer Drugs Sales by Country
    • 3.3.2 North America Platinum-based Anticancer Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Platinum-based Anticancer Drugs Sales by Country
    • 3.4.2 Europe Platinum-based Anticancer Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Platinum-based Anticancer Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Platinum-based Anticancer Drugs Sales by Region
    • 3.5.2 Asia Pacific Platinum-based Anticancer Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Platinum-based Anticancer Drugs Sales by Country
    • 3.6.2 Latin America Platinum-based Anticancer Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Platinum-based Anticancer Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Platinum-based Anticancer Drugs Sales by Country
    • 3.7.2 Middle East and Africa Platinum-based Anticancer Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Platinum-based Anticancer Drugs Historic Market Analysis by Type

  • 4.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Platinum-based Anticancer Drugs Price by Type (2016-2021)

5 Global Platinum-based Anticancer Drugs Historic Market Analysis by Application

  • 5.1 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Platinum-based Anticancer Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Sanofi-Aventis
    • 6.1.1 Sanofi-Aventis Corporation Information
    • 6.1.2 Sanofi-Aventis Description and Business Overview
    • 6.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Sanofi-Aventis Product Portfolio
    • 6.1.5 Sanofi-Aventis Recent Developments/Updates
  • 6.2 Yakult honsha
    • 6.2.1 Yakult honsha Corporation Information
    • 6.2.2 Yakult honsha Description and Business Overview
    • 6.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Yakult honsha Product Portfolio
    • 6.2.5 Yakult honsha Recent Developments/Updates
  • 6.3 Dr Reddy's laboratories
    • 6.3.1 Dr Reddy's laboratories Corporation Information
    • 6.3.2 Dr Reddy's laboratories Description and Business Overview
    • 6.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Dr Reddy's laboratories Product Portfolio
    • 6.3.5 Dr Reddy's laboratories Recent Developments/Updates
  • 6.4 Sun Pharmaceutical
    • 6.4.1 Sun Pharmaceutical Corporation Information
    • 6.4.2 Sun Pharmaceutical Description and Business Overview
    • 6.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sun Pharmaceutical Product Portfolio
    • 6.4.5 Sun Pharmaceutical Recent Developments/Updates
  • 6.5 Teva
    • 6.5.1 Teva Corporation Information
    • 6.5.2 Teva Description and Business Overview
    • 6.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Teva Product Portfolio
    • 6.5.5 Teva Recent Developments/Updates
  • 6.6 Fresenius Kabi
    • 6.6.1 Fresenius Kabi Corporation Information
    • 6.6.2 Fresenius Kabi Description and Business Overview
    • 6.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Fresenius Kabi Product Portfolio
    • 6.6.5 Fresenius Kabi Recent Developments/Updates
  • 6.7 Hospira(Pfizer)
    • 6.6.1 Hospira(Pfizer) Corporation Information
    • 6.6.2 Hospira(Pfizer) Description and Business Overview
    • 6.6.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hospira(Pfizer) Product Portfolio
    • 6.7.5 Hospira(Pfizer) Recent Developments/Updates
  • 6.8 Mylan
    • 6.8.1 Mylan Corporation Information
    • 6.8.2 Mylan Description and Business Overview
    • 6.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Mylan Product Portfolio
    • 6.8.5 Mylan Recent Developments/Updates
  • 6.9 Taj Pharmaceuticals
    • 6.9.1 Taj Pharmaceuticals Corporation Information
    • 6.9.2 Taj Pharmaceuticals Description and Business Overview
    • 6.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Taj Pharmaceuticals Product Portfolio
    • 6.9.5 Taj Pharmaceuticals Recent Developments/Updates
  • 6.10 Jiangsu Hengrui Medicine
    • 6.10.1 Jiangsu Hengrui Medicine Corporation Information
    • 6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
    • 6.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Jiangsu Hengrui Medicine Product Portfolio
    • 6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
  • 6.11 Nanjing Pharmaceutical Factory
    • 6.11.1 Nanjing Pharmaceutical Factory Corporation Information
    • 6.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Description and Business Overview
    • 6.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Nanjing Pharmaceutical Factory Product Portfolio
    • 6.11.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
  • 6.12 Jiangsu Aosaikang Pharmaceutical
    • 6.12.1 Jiangsu Aosaikang Pharmaceutical Corporation Information
    • 6.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
    • 6.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Jiangsu Aosaikang Pharmaceutical Product Portfolio
    • 6.12.5 Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
  • 6.13 Qilu Pharmaceutical
    • 6.13.1 Qilu Pharmaceutical Corporation Information
    • 6.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
    • 6.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Qilu Pharmaceutical Product Portfolio
    • 6.13.5 Qilu Pharmaceutical Recent Developments/Updates
  • 6.14 Hisun Pharmaceutical
    • 6.14.1 Hisun Pharmaceutical Corporation Information
    • 6.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Description and Business Overview
    • 6.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Hisun Pharmaceutical Product Portfolio
    • 6.14.5 Hisun Pharmaceutical Recent Developments/Updates
  • 6.15 Luoxin
    • 6.15.1 Luoxin Corporation Information
    • 6.15.2 Luoxin Platinum-based Anticancer Drugs Description and Business Overview
    • 6.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Luoxin Product Portfolio
    • 6.15.5 Luoxin Recent Developments/Updates
  • 6.16 Lingnan Pharmacy
    • 6.16.1 Lingnan Pharmacy Corporation Information
    • 6.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Description and Business Overview
    • 6.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Lingnan Pharmacy Product Portfolio
    • 6.16.5 Lingnan Pharmacy Recent Developments/Updates
  • 6.17 Hansoh Pharma
    • 6.17.1 Hansoh Pharma Corporation Information
    • 6.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Description and Business Overview
    • 6.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Hansoh Pharma Product Portfolio
    • 6.17.5 Hansoh Pharma Recent Developments/Updates

7 Platinum-based Anticancer Drugs Manufacturing Cost Analysis

  • 7.1 Platinum-based Anticancer Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Platinum-based Anticancer Drugs
  • 7.4 Platinum-based Anticancer Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Platinum-based Anticancer Drugs Distributors List
  • 8.3 Platinum-based Anticancer Drugs Customers

9 Platinum-based Anticancer Drugs Market Dynamics

  • 9.1 Platinum-based Anticancer Drugs Industry Trends
  • 9.2 Platinum-based Anticancer Drugs Growth Drivers
  • 9.3 Platinum-based Anticancer Drugs Market Challenges
  • 9.4 Platinum-based Anticancer Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Platinum-based Anticancer Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Type (2022-2027)
  • 10.2 Platinum-based Anticancer Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Application (2022-2027)
  • 10.3 Platinum-based Anticancer Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Platinum-based Anticancer Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Platinum-based Anticancer Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Cisplatin
    Carboplatin
    Oxaliplatin
    Nedaplatin
    Others

    Segment by Application
    Testicular Cancer
    Osteosarcoma
    Breast Cancer
    Esophageal Cancer
    NSCLC
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Sanofi-Aventis
    Yakult honsha
    Dr Reddy's laboratories
    Sun Pharmaceutical
    Teva
    Fresenius Kabi
    Hospira(Pfizer)
    Mylan
    Taj Pharmaceuticals
    Jiangsu Hengrui Medicine
    Nanjing Pharmaceutical Factory
    Jiangsu Aosaikang Pharmaceutical
    Qilu Pharmaceutical
    Hisun Pharmaceutical
    Luoxin
    Lingnan Pharmacy
    Hansoh Pharma

    Buy now